Corpus ID: 26648972

Alzheimer ’ s disease • Par inson ’ s disease Smoking and mental health k • Impact of smokefree policies • Smoking cessation Smoking trends

  title={Alzheimer ’ s disease • Par inson ’ s disease Smoking and mental health k • Impact of smokefree policies • Smoking cessation Smoking trends},


Interventions for smoking cessation and reduction in individuals with schizophrenia.
Bupropion increases smoking abstinence rates in smokers with schizophrenia, without jeopardizing their mental state and varenicline may also improve smoking cessation rates in schizophrenia, but its possible psychiatric adverse effects cannot be ruled out. Expand
The Delivery of Stop Smoking Support to People with Mental Health Conditions: A Survey of NHS Stop Smoking Services
NHS Stop Smoking Services may not be operating appropriate procedures for supporting people with mental health problems and there is a need for local protocols to be implemented that include routine screening for mental health issues and liaison withmental health care providers. Expand
Implementation of smoke-free policies in mental health in-patient settings in England
It is indicated that sustained policy enforcement was perceived as difficult, but that despite challenges and concerns, the impact of the policy was regarded as beneficial, with some evidence of positive behavioural changes occurring in people. Expand
Social patterning of individual health behaviours: The case of cigarette smoking
This chapter first considers the nature and extent of the association of smoking with indicators of disadvantage, and trends in rates of current and ex-smoking by deprivation, before addressing the question of why poor people are more likely to smoke and why they find it harder to give up. Expand
Review of smoking cessation treatments for people with mental illness
This article reviews the current literature regarding treatments for smoking cessation in both the general population and in those with mental health problems and recommends pharmacotherapy coupled with individual or group psychological support. Expand
Tobacco Smoking within Psychiatric Inpatient Settings: Biopsychosocial Perspective
Evidence relating to the clinical impact of tobacco smoking within inpatient psychiatric settings is discussed, with a particular focus on the influence of smoking on the physical and mental health, pharmacotherapy, and social interactions of patients during their inpatient stay. Expand
A survey of staff attitudes to smoking-related policy and intervention in psychiatric and general health care settings.
Staff attitudes need to be carefully considered, particularly in psychiatric settings, in attempts to implement smoke-free policies in health care settings, as well as on the role of staff in stop smoking intervention. Expand
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.
Bipolar patients with lifetime smoking were more likely to have earlier age at onset of mood disorder, greater severity of symptoms, poorer functioning, history of a suicide attempt, and a lifetime history of comorbid anxiety and substance use disorders. Expand
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.
  • S. Oddo, A. Caccamo, +5 authors F. LaFerla
  • Chemistry, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2005
These data show that nicotine exacerbates tau pathology in vivo and highlights the importance of testing compounds designed to ameliorate AD pathology in a model with both neuropathological lesions because of the differential effects it can have on either Abeta or tau. Expand
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia
  • Archives of Gen Psych
  • 2005